Skip to main content

Fluorescence-Based, High-Throughput Assays for μ-Opioid Receptor Activation Using a Membrane Potential-Sensitive Dye

  • Protocol
  • First Online:
Opioid Receptors

Part of the book series: Methods in Molecular Biology ((MIMB,volume 1230))

Abstract

The development of new and improved opioid analgesics requires high-throughput screening (HTS) methods to identify potential therapeutics from large libraries of lead compounds. Here we describe two simple, real-time fluorescence-based assays of μ-opioid receptor activation that may be scaled up for HTS. In AtT-20 cells expressing the μ-opioid receptor (MOPr), opioids activate endogenous G protein gated inwardly rectifying K channels (GIRK channels), leading to membrane hyperpolarization. In Chinese hamster ovary cells expressing MOPr, adenylyl cyclase activation via forskolin results in membrane hyperpolarization, which is inhibited by opioids. Changes in membrane potential can be measured using a proprietary membrane potential-sensitive dye. In contrast to many HTS methods currently available, these assays reflect naturalistic coupling of the receptor to effector molecules.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Matthes HWD, Maldonado R, Simonin F et al (1996) Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the μ-opioid-receptor gene. Nature 383:819–823

    Article  PubMed  CAS  Google Scholar 

  2. Kenakin T, Miller LJ (2010) Seven transmembrane receptors as shapeshifting proteins: the impact of allosteric modulation and functional selectivity on new drug discovery. Pharmacol Rev 62:265–304

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  3. Pinyero G, Archer-Lahlou E (2007) Ligand-specific receptor states: implications for opiate receptor signaling and regulation. Cell Signal 19:8–19

    Article  Google Scholar 

  4. DeWire SM, Yamashita DS, Rominger DH et al (2013) A G protein-biased ligand at the μ-opioid receptor is potently analgesic with reduced gastrointestinal and respiratory dysfunction compared with morphine. J Pharmacol Exp Ther 344:708–717

    Article  PubMed  CAS  Google Scholar 

  5. Kenakin T, Christopoulos A (2013) Signalling bias in new drug discovery: detection, quantification and therapeutic impact. Nat Rev Drug Discov 12:205–216

    Article  PubMed  CAS  Google Scholar 

  6. Pradhan AA, Smith ML, Kieffer BL et al (2012) Ligand-directed signalling within the opioid receptor family. Br J Pharmacol 167:960–969

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  7. Zheng H, Loh HH, Law PY (2013) Post-translation modification of G protein-copuled receptor in relationship to biased agonism. Methods Enzymol 522:391–408

    Article  PubMed  CAS  Google Scholar 

  8. Coward P, Chan SDH, Wada HG et al (1999) Chimeric G-proteins allow a high-throughput signaling assay of Gi-coupled receptors. Anal Biochem 270:242–248

    Article  PubMed  CAS  Google Scholar 

  9. Hill SJ, Williams C, May LT (2010) Insights into GPCR pharmacology from the measurement of changes in intracellular cyclic AMP: Advantages and pitfalls of differing methodologies. Br J Pharmacol 161:1266–1275

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  10. Celver J, Xu M, Jin W et al (2004) Distinct domains of the μ-opioid receptor control uncoupling and internalization. Mol Pharmacol 65:528–537

    Article  PubMed  CAS  Google Scholar 

  11. Knapman A, Santiago M, Du YP et al (2013) A continuous, fluorescence-based assay of μ-opioid receptor activation in AtT-20 cells. J Biomol Screen 18:269–276

    Article  PubMed  CAS  Google Scholar 

  12. Gabriel D, Vernier M, Pfeifer MJ et al (2003) High throughput screening technologies for direct cyclic AMP measurement. Assay Drug Dev Technol 1:291–303

    Article  PubMed  CAS  Google Scholar 

  13. Williams C (2004) cAMP detection methods in HTS: Selecting the best from the rest. Nat Rev Drug Discov 3:125–135

    Article  PubMed  CAS  Google Scholar 

  14. Binkowski BF, Fan F, Wood KV (2011) Luminescent biosensors for real time monitoring of intracellular cAMP. Methods Mol Biol 756:263–271

    Article  PubMed  CAS  Google Scholar 

  15. Knapman A, Abodadie F, McIntyre P et al (2014) A real-time, fluorescence-based assay for measuring μ-opioid receptor modulation of adenylyl cyclase activity in Chinese hamster ovary cells. J Biomol Screen 19:223–231

    Article  PubMed  Google Scholar 

  16. Zhang J, Chung TDY, Oldenburg KR (1999) A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J Biomol Screen 4:67–73

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mark Connor .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media New York

About this protocol

Cite this protocol

Knapman, A., Connor, M. (2015). Fluorescence-Based, High-Throughput Assays for μ-Opioid Receptor Activation Using a Membrane Potential-Sensitive Dye. In: Spampinato, S. (eds) Opioid Receptors. Methods in Molecular Biology, vol 1230. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-1708-2_14

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-1708-2_14

  • Published:

  • Publisher Name: Humana Press, New York, NY

  • Print ISBN: 978-1-4939-1707-5

  • Online ISBN: 978-1-4939-1708-2

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics